Browsing Tag
JANX007
2 posts
How next-generation masking strategies could reshape PSMA-directed T cell engager development
How Janux Therapeutics is advancing masked T cell engagers with JANX014. Find out what this means for prostate cancer treatment and immunotherapy.
Janux Therapeutics advances prostate cancer treatment as stock soars
Janux Therapeutics made headlines with an extraordinary 54% surge in after-hours trading on Monday, bringing its stock price…